Arine’s Post

A robust data management strategy is crucial for payers to deliver “more personalized, proactive, and comprehensive care management” as discussed in this article from Wolters Kluwer Health. And it is core to Arine's strategy. By leveraging AI and integrating clinical expertise, Arine is at the forefront of driving data-driven care management. We leverage the unique position of the pharmacy team to incorporate emotional, social, and environmental factors into clinical care recommendations to help identify and address barriers to care and ultimately improve outcomes at scale. #datadriven #caremanagement #pharmacy #healthinnovation 👉Read more: https://hubs.li/Q02J19y90

Adherence to medications for cholesterol, hypertension and diabetes helped Medicare beneficiaries avoid up to $29.2 billion dollars in health care costs over a six-year period from 2016-21. This CMS finding highlights the value of high-impact quality measures for chronic conditions. At Arine, we are harnessing the power of AI to help health plans achieve these cost savings and support their populations with better chronic condition management. Of note are the results we are also able to drive in addressing health equity, which will be integral to quality measurement moving forward as emphasized by Micah Cost, CEO of the Pharmacy Quality Alliance in this Managed Healthcare Executive article. 👉Read more: https://hubs.li/Q02HKJj70

Want to learn more about how AI models, like those Arine uses, improve healthcare? Check out this webinar from Stanford Online where Nigam Shah, Chief Data Scientist for Stanford Health Care, describes use cases for machine learning in healthcare and emphasizes the importance of ensuring these models are useful, reliable, and fair. Arine’s platform is one such use case, where we are using AI models to guide clinical interventions for optimizing medications in an equitable way, at the population level. As a result, we enable better outcomes and meaningful reductions in total cost of care for our health plan partners. #AI #healthcare #outcomes https://hubs.li/Q02H7CRl0

In one study published in the JAMA Network, researchers estimated that, in 2018, racial and ethnic-based health disparities carried an economic burden for the US of up to $451 billion, the equivalent of $1,377 per person. How do we even begin to address these disparities? We can start by identifying those disparities most prevalent in our own member populations and applying a structured quality improvement approach to the issues identified. Medication optimization plays a crucial role in addressing health disparities, but requires insight to member-specific needs to have the greatest impact. Learn more about how Arine's AI-powered insights and tools are helping clinicians reduce health disparities and improve quality of care. #qualityimprovement #healthdisparities #healthequity #medicationoptimization 👉Read more in our most recent blog post: https://hubs.li/Q02GPBV60

We're growing and looking for a new Head of People. See below for details.

Clinical excellence, supported by a well-designed, AI-powered software platform like Arine's, is key to ensuring that patients get the greatest benefit and value from our medications. It is a keystone to best-in-class comprehensive medication management. Pharmacists play a vital clinical role in this equation and the scope of their responsibilities is ever-increasing. Want to learn more? This overview from Pharmacy Times attests to the breadth and depth of knowledge that pharmacists deploy day in and day out. https://hubs.li/Q02FVbxp0

Achieving health equity is a challenge, especially when your zip code can determine how healthy you are. As can your race, gender, sexual orientation, or education level. Social determinants of health such as these, drive 70% of health outcomes—but there are ways to close the gap. Quality improvement provides an opportunity for health plans to identify and address healthcare disparities tied to social determinants of health. With Arine's AI-powered medication intelligence platform, clinical teams get insights into the member’s specific needs, allowing them to more effectively tailor their interventions and address any barriers the patient may have to getting the right care. It is through increased personalization like this that we will get closer to addressing healthcare disparities and achieving health equity. 👀Read our latest blog post to learn more. https://hubs.li/Q02DMYNJ0 #QualityImprovement #HealthEquity #SDoH #AI #MedicationIntelligence

Patient outcomes “determine everything we do; what products we build, what new features we’re adding.” - Yoona Kim, co-founder and CEO of Arine speaking at Flare Capital Partners' Expert Roundtable earlier this week. This unwavering focus on patient needs and outcomes is what is driving Arine and others to innovate in the pharmacy space. Critical for success though, as noted in the conversation, is being in the flow of funds and driving value for payers and providers, as well as patients. Thank you Flare Capital Partners for getting this group of leaders together to discuss pharmacy technology innovation! 👉 Watch the recording here: https://hubs.li/Q02DCgY70 #PharmacyTech #HealthcareInnovation #HealthOutcomes

“How does a human sort through vast amounts of data and get it right every time?” This was the question our CEO, Yoona Kim, posed in a recent interview for @POLITICO, when addressing the ability of AI to synthesize large data sets and improve the precision of medication prescribing. Yoona discussed how Arine's AI platform analyzes multiple clinical and contextual data sources to ensure patients are on the right medications at the right dose. Providers are then equipped with these data-based recommendations to provide the best care for their patients. Read more on POLITICO's ‘Future Pulse’ newsletter: https://hubs.ly/Q02Dkjzd0.

Don't miss out! Hear Arine's CEO and co-founder, Yoona Kim, along with an esteemed panel of experts TOMORROW June 25 at 9am PT. Registration link below.